La nostra recerca

Fruit de la recerca, el GReMII ha desenvolupat les següents patents

PATENTS TITOL  
EP17382246.1. (2017) PREDICTIVE RESPONSE BIOMARKERS TO CORTICOSTEROIDS PATENT INTERNACIONAL
PCT/EP2008065950 (2008) Strains of Lactobacillus plantarum as probiotics Patent internacional

 

Aquí pots trobar les beques competitives obtingudes en els darrers 5 anys per membres del GReMII.

BEQUES TïTOL ENTITAT FINANCIADORA
PI16/01937 Validación de biomarcadores plasmáticos de respuesta a corticoides e identificación de mecanismos epigenéticos asociados a la corticorefractariedad en la colitis ulcerosa. Instituto de Salud Carlos III (Fondo de Investigación Sanitaria)
PI13/02198 Evaluación del microbioma intestinal en la enfermedad de Crohn y su relación con el genoma y el transcriptoma en la búsqueda de señales predictivas de recurrencia post quirúrgica. Instituto de Salud Carlos III (Fondo de Investigación Sanitaria)
PI12/00621 Implicación de la actividad de matriz extracelular en la aparición de complicaciones evolutivas en

la enfermedad de Crohn y en el desarrollo de nuevas propuestas terapéuticas.

Instituto de Salud Carlos III (Fondo de Investigación Sanitaria)
PI11/01691 Caracterización del perfil génico en la respuesta a corticoesteroides en pacientes con colitis ulcerosa Instituto de Salud Carlos III (Fondo de Investigación Sanitaria)
PI09/01294 Perfil genético funcional en la enfermedad de Crohn. Efecto sobre el desarrollo de recurrencia post-quirúrgica. Instituto de Salud Carlos III (Fondo de Investigación Sanitaria)
Beca AEG – GETECCU 2017 Validación de biomarcadores plasmáticos e identificación de posibles biomarcadores fecales asociados a la corticorefractariedad en la colitis ulcerosa Asociación Española de Gastroenterología
Beca XIX GETECCU-Faes Farma_2016 Monitorización de la Recurrencia Postquirúrgica (RPQ) en la enfermedad de Crohn mediante una estrategia basada en la determinación periódica de la calproctectina fecal en pacientes con un primer control endoscópico negativo Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
X Beca GETECCU-OTZUKA 2013 Evaluación de la vía de señalización Notch como biomarcador de la aparición precoz de recurrencia postquirúrgica en la enfermedad de Crohn. Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
VALUNI16-1-0001 Biomarcadors de resposta als corticosteroides en la colitis ulcerosa ACCIO10;  Generalitat de Catalunya

 

Aquí trobaràs les publicacions científiques dels treballs que hem liderat o en els que hem col·laborat. Clica al link per accedir al resum.

 

1. Genetic variation associated with cardiovascular risk in autoimmune diseases.
Perrotti PP, Aterido A, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Domènech E, Fernández-Gutiérrez B, Gomollón F, García-Planella E, Fernández E, Sanmartí R, Gratacós J, Martínez-Taboada VM, Rodríguez-Rodríguez L, Palau N, Tortosa R, Corbeto ML, Lasanta ML, Marsal S, Julià A; IMID Consortium.
PLoS One. 2017 Oct 5;12(10):e0185889. doi: 10.1371/journal.pone.0185889. eCollection 2017.
2. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
Calafat M, Lobatón T, Hernández-Gallego A, Mañosa M, Torres P, Cañete F, Cabré E, Ojanguren I, Domènech E.
Dig Liver Dis. 2017 Sep 8. pii: S1590-8658(17)31061-7. doi: 10.1016/j.dld.2017.08.041. [Epub ahead of print]
PMID: 28958412 [PubMed – as supplied by publisher]
Similar articles
3. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
Ordás I, Domènech E, Mañosa M, García-Sánchez V, Iglesias-Flores E, Peñalva M, Cañas-Ventura A, Merino O, Fernández-Bañares F, Gomollón F, Vera M, Gutiérrez A, Garcia-Planella E, Chaparro M, Aguas M, Gento E, Muñoz F, Aguirresarobe M, Muñoz C, Fernández L, Calvet X, Jiménez CE, Montoro MA, Mir A, De Castro ML, García-Sepulcre MF, Bermejo F, Panés J, Esteve M.
Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.180. [Epub ahead of print]
PMID: 28675163 [PubMed – as supplied by publisher]
Similar articles
4. Cytomegalovirus primoinfection in inflammatory bowel disease.
Torres P, Lobatón T, Cañete F, Clos A, Mañosa M, Cabré E, Domènech E.
Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161-9. doi: 10.1016/j.gastrohep.2017.06.008. [Epub ahead of print] English, Spanish. No abstract available.
PMID: 28734481 [PubMed – as supplied by publisher]
Similar articles
5. Therapeutic requirements in active ulcerative proctitis: A single-centre study.
Calafat M, Lobatón T, Mañosa M, Marín L, Caballero N, Larraín M, Cabré E, Domènech E.
Gastroenterol Hepatol. 2017 Jun 27. pii: S0210-5705(17)30129-2. doi: 10.1016/j.gastrohep.2017.05.006. [Epub ahead of print] English, Spanish.
PMID: 28666605 [PubMed – as supplied by publisher]
Similar articles
6. Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.
Fernández-Gutiérrez B, Perrotti PP, Gisbert JP, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, García-Sánchez V, Panés J, Fonseca E, Blanco F, Rodríguez-Moreno J, Carreira P, Julià A, Marsal S, Rodriguez-Rodriguez L; IMID Consortium.
Medicine (Baltimore). 2017 Jun;96(26):e7308. doi: 10.1097/MD.0000000000007308.
PMID: 28658137 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
7. Incidence and Management of Recurrence in Patients with Crohn’s Disease Who Have Undergone Intestinal Resection: The Practicrohn Study.
Domènech E, Garcia V, Iborra M, Gutiérrez A, García-López S, Martín Arranz MD, Garcia-Planella E, Calvo M, Castro L, Mínguez M, Taxonera C, Juliá B, Cea-Calvo L, Romero C, Barreiro-de Acosta M.
Inflamm Bowel Dis. 2017 Oct;23(10):1840-1846. doi: 10.1097/MIB.0000000000001180.
PMID: 28644182 [PubMed – in process]
Similar articles
8. Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn’s disease.
Domènech E, López-Sanromán A, Nos P, Vera M, Chaparro M, Esteve M, Gisbert JP, Mañosa M; en representación de GETECCU.
Gastroenterol Hepatol. 2017 Aug – Sep;40(7):472-483. doi: 10.1016/j.gastrohep.2017.05.005. Epub 2017 Jun 9. English, Spanish.
PMID: 28606755 [PubMed]
Similar articles
9. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
Chaparro M, Ramas M, Benítez JM, López-García A, Juan A, Guardiola J, Mínguez M, Calvet X, Márquez L, Fernández Salazar LI, Bujanda L, García C, Zabana Y, Lorente R, Barrio J, Hinojosa E, Iborra M, Cajal MD, Van Domselaar M, García-Sepulcre MF, Gomollón F, Piqueras M, Alcaín G, García-Sánchez V, Panés J, Domènech E, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP.
Am J Gastroenterol. 2017 Jul;112(7):1135-1143. doi: 10.1038/ajg.2017.96. Epub 2017 May 23.
PMID: 28534520 [PubMed – indexed for MEDLINE]
Similar articles
10. Epstein-Barr virus-positive mucocutaneous ulcer in Crohn’s disease. A condition to consider in immunosuppressed IBD patients.
Juan A, Lobatón T, Tapia G, Mañosa M, Cabré E, Domènech E.
Dig Liver Dis. 2017 Aug;49(8):934-937. doi: 10.1016/j.dld.2017.03.011. Epub 2017 Mar 28.
PMID: 28454852 [PubMed – in process]
Similar articles
11. Adalimumab Vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A Geteccu Randomized Trial.
López-Sanromán A, Vera-Mendoza I, Domènech E, Taxonera C, Vega Ruiz V, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Pons V, Nos P; Spanish GETECCU group (APPRECIA study).
J Crohns Colitis. 2017 Apr 11. doi: 10.1093/ecco-jcc/jjx051. [Epub ahead of print]
PMID: 28402454 [PubMed – as supplied by publisher]
Similar articles
12. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
Panés J, Domènech E, Aguas Peris M, Nos P, Riestra S, Juliá B, Cea-Calvo L, Romero C, Marín-Jiménez I.
J Gastroenterol Hepatol. 2017 Mar 29. doi: 10.1111/jgh.13795. [Epub ahead of print]
PMID: 28370253 [PubMed – as supplied by publisher]
Similar articles
13. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP.
Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13.
PMID: 27958281 [PubMed – indexed for MEDLINE]
Similar articles
14. Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn’s Disease.
Garcia-Planella E, Mañosa M, Cabré E, Marín L, Gordillo J, Zabana Y, Boix J, Sáinz S, Domènech E.
Inflamm Bowel Dis. 2016 Dec;22(12):2879-2885.
PMID: 27824646 [PubMed – in process]
Similar articles
15. Urine metabolome profiling of immune-mediated inflammatory diseases.
Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S; IMID Consortium.
BMC Med. 2016 Sep 8;14(1):133. doi: 10.1186/s12916-016-0681-8.
PMID: 27609333 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
16. Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative Statistics.
Katsanos KH, Domènech E, Rahier JF, Kopylov U, Fiorino G, Rogler G, Louis E, Ben-Horin S.
J Crohns Colitis. 2017 Feb;11(2):256-257. doi: 10.1093/ecco-jcc/jjw131. Epub 2016 Jul 19. No abstract available.
PMID: 27436436 [PubMed – indexed for MEDLINE] Free Article
Similar articles
17. Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile.
Lobatón T, Domènech E.
Inflamm Bowel Dis. 2016 Jul;22(7):1755-62. doi: 10.1097/MIB.0000000000000788.
PMID: 27104824 [PubMed – in process]
Similar articles
18. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
Llaó J, Naves JE, Ruiz-Cerulla A, Gordillo J, Mañosa M, Maisterra S, Cabré E, Garcia-Planella E, Guardiola J, Domènech E.
Dig Liver Dis. 2016 Jun;48(6):608-12. doi: 10.1016/j.dld.2016.02.024. Epub 2016 Mar 5.
PMID: 27012443 [PubMed – indexed for MEDLINE]
Similar articles
19. Effectiveness of anti-TNFα drugs in patients with Crohn’s disease who do not achieve remission with their first anti-TNFα agent.
R-Grau Mdel C, Chaparro M, Mesonero F, Barreiro-de Acosta M, Castro L, Castro M, Domènech E, Mancenido N, Pérez-Calle JL, Taxonera C, Barrio J, De Francisco R, Fernández-Salgado E, Luzón L, Merino O, Oltra L, Saro C, Bermejo F, García-Sánchez V, Ginard D, Gutiérrez A, Vera I, Antón R, Ber Y, Calvet X, Gisbert JP.
Dig Liver Dis. 2016 Jun;48(6):613-9. doi: 10.1016/j.dld.2016.02.012. Epub 2016 Mar 2.
PMID: 26992847 [PubMed – indexed for MEDLINE]
Similar articles
20. Efficacy and safety of vedolizumab in the treatment of ulcerative colitis.
Domènech E, Gisbert JP.
Gastroenterol Hepatol. 2016 Dec;39(10):677-686. doi: 10.1016/j.gastrohep.2015.11.010. Epub 2016 Mar 2. English, Spanish.
PMID: 26948838 [PubMed – in process]
Similar articles
21. Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
Marín-Jiménez I, Nos P, Domènech E, Riestra S, Gisbert JP, Calvet X, Cortés X, Iglesias E, Huguet JM, Taxonera C, Fernández R, Carpio D, Gutiérrez A, Guardiola J, Laria LC, Sicilia B, Bujanda L, Cea-Calvo L, Romero C, Rincón Ó, Juliá B, Panés J.
Am J Gastroenterol. 2016 Feb;111(2):261-8. doi: 10.1038/ajg.2015.403. Epub 2016 Jan 12.
PMID: 26753886 [PubMed – indexed for MEDLINE]
Similar articles
22. Outcome after a dose “de-intensification” strategy with anti-TNF drugs in patients with Crohn’s disease.
Chaparro M, Barreiro-de Acosta M, García-Planella E, Domènech E, Bermejo F, Calvet X, Martín Arranz MD, Monfort D, Gisbert JP.
Gastroenterol Hepatol. 2016 Apr;39(4):255-60. doi: 10.1016/j.gastrohep.2015.06.007. Epub 2015 Nov 24.
PMID: 26620278 [PubMed – indexed for MEDLINE]
Similar articles
23. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J, Cabré E, Garcia-Planella E, Ricart E, Ber-Nieto Y, Márquez L, Rodríguez-Moranta F, Ponferrada Á, Vera I, Gisbert JP, Barrio J, Esteve M, Merino O, Muñoz F, Domènech E; ENEIDA Project of the Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU).
J Crohns Colitis. 2015 Dec;9(12):1063-70. doi: 10.1093/ecco-jcc/jjv145. Epub 2015 Sep 7.
PMID: 26351379 [PubMed – indexed for MEDLINE]
Similar articles
24. Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis.
Lorén V, Cabré E, Ojanguren I, Domènech E, Pedrosa E, García-Jaraquemada A, Mañosa M, Manyé J.
PLoS One. 2015 Jun 19;10(6):e0130921. doi: 10.1371/journal.pone.0130921. eCollection 2015.
PMID: 26090671 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
25. High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?
Calafat M, Cabré E, Mañosa M, Lobatón T, Marín L, Domènech E.
Inflamm Bowel Dis. 2015 May;21(5):1072-6. doi: 10.1097/MIB.0000000000000349.
PMID: 25793326 [PubMed – indexed for MEDLINE]
Similar articles
26. [Vedolizumab in the treatment of Crohn’s disease].
Gisbert JP, Domènech E.
Gastroenterol Hepatol. 2015 May;38(5):338-48. doi: 10.1016/j.gastrohep.2014.12.003. Epub 2015 Jan 23. Review. Spanish.
PMID: 25619903 [PubMed – indexed for MEDLINE]
Similar articles
27. Identification of risk loci for Crohn’s disease phenotypes using a genome-wide association study.
Alonso A, Domènech E, Julià A, Panés J, García-Sánchez V, Mateu PN, Gutiérrez A, Gomollón F, Mendoza JL, Garcia-Planella E, Barreiro-de Acosta M, Muñoz F, Vera M, Saro C, Esteve M, Andreu M, Chaparro M, Manyé J, Cabré E, López-Lasanta M, Tortosa R, Gelpí JL, García-Montero AC, Bertranpetit J, Absher D, Myers RM, Marsal S, Gisbert JP.
Gastroenterology. 2015 Apr;148(4):794-805. doi: 10.1053/j.gastro.2014.12.030. Epub 2014 Dec 31.
PMID: 25557950 [PubMed – indexed for MEDLINE]
Similar articles
28. [Reccomendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
Gomollón F, Rubio S, Charro M, García-López S, Muñoz F, Gisbert JP, Domènech E; En Representación de GETECCU.
Gastroenterol Hepatol. 2015 Jan;38(1):24-30. doi: 10.1016/j.gastrohep.2014.10.002. Epub 2014 Nov 13. Spanish.
PMID: 25454602 [PubMed – indexed for MEDLINE]
Similar articles
29. Optimizing post-operative Crohn’s disease treatment.
Domènech E, Mañosa M, Lobatón T, Cabré E.
Ann Gastroenterol. 2014;27(4):313-319. Review.
PMID: 25331779 [PubMed – as supplied by publisher] Free PMC Article
Similar articles
30. A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis.
Julià A, Domènech E, Chaparro M, García-Sánchez V, Gomollón F, Panés J, Mañosa M, Barreiro-De Acosta M, Gutiérrez A, Garcia-Planella E, Aguas M, Muñoz F, Esteve M, Mendoza JL, Vera M, Márquez L, Tortosa R, López-Lasanta M, Alonso A, Gelpí JL, García-Montero AC, Bertranpetit J, Absher D, Myers RM, Gisbert JP, Marsal S.
Hum Mol Genet. 2014 Dec 20;23(25):6927-34. doi: 10.1093/hmg/ddu398. Epub 2014 Jul 31.
PMID: 25082827 [PubMed – indexed for MEDLINE]
Similar articles
31. Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids.
Llaó J, Naves JE, Ruiz-Cerulla A, Marín L, Mañosa M, Rodríguez-Alonso L, Cabré E, Garcia-Planella E, Guardiola J, Domènech E.
J Crohns Colitis. 2014 Nov;8(11):1523-8. doi: 10.1016/j.crohns.2014.06.010. Epub 2014 Jul 22.
PMID: 25066954 [PubMed – indexed for MEDLINE]
Similar articles
32. Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks.
Naves JE, Llaó J, Ruiz-Cerulla A, Romero C, Mañosa M, Lobatón T, Cabré E, Garcia-Planella E, Guardiola J, Domènech E.
Inflamm Bowel Dis. 2014 Aug;20(8):1375-81. doi: 10.1097/MIB.0000000000000101.
PMID: 25046008 [PubMed – indexed for MEDLINE]
Similar articles
33. An overview of the natural history of inflammatory bowel diseases.
Domènech E, Mañosa M, Cabré E.
Dig Dis. 2014;32(4):320-7. doi: 10.1159/000358131. Epub 2014 Jun 23. Review.
PMID: 24969275 [PubMed – indexed for MEDLINE]
Similar articles
34. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
Cañas-Ventura A, Márquez L, Ricart E, Domènech E, Gisbert JP, García-Sanchez V, Marín-Jiménez I, Rodriguez-Moranta F, Gomollón F, Calvet X, Merino O, Garcia-Planella E, Vázquez-Romero N, Esteve M, Iborra M, Gutiérrez A, Vera M, Andreu M; Spanish GETECCU group (ENEIDA project).
J Crohns Colitis. 2014 Oct;8(10):1287-93. doi: 10.1016/j.crohns.2014.03.014. Epub 2014 Apr 13.
PMID: 24726696 [PubMed – indexed for MEDLINE]
Similar articles
35. Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn’s disease despite preventive thiopurine therapy: A case-control study.
Zabana Y, Mañosa M, Cabré E, Bernal I, Marín L, Lorenzo-Zúñiga V, Moreno V, Boix J, Domènech E.
J Gastroenterol Hepatol. 2014;29(7):1413-7. doi: 10.1111/jgh.12579.
PMID: 24627958 [PubMed – indexed for MEDLINE]
Similar articles
36. Phenotypic concordance in familial inflammatory bowel disease (IBD). Results of a nationwide IBD Spanish database.
Cabré E, Mañosa M, García-Sánchez V, Gutiérrez A, Ricart E, Esteve M, Guardiola J, Aguas M, Merino O, Ponferrada A, Gisbert JP, Garcia-Planella E, Ceña G, Cabriada JL, Montoro M, Domènech E; ENEIDA Project of the Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU).
J Crohns Colitis. 2014 Jul;8(7):654-61. doi: 10.1016/j.crohns.2013.12.005. Epub 2013 Dec 30.
PMID: 24388046 [PubMed – indexed for MEDLINE]
Similar articles
37. [Acute pericarditis associated with oral or topical mesalazine therapy in patients with ulcerative colitis].
Calafat M, Mañosa M, Cabré E, Domènech E.
Gastroenterol Hepatol. 2014 Apr;37(4):254-5. doi: 10.1016/j.gastrohep.2013.09.004. Epub 2013 Dec 14. Spanish. No abstract available.
PMID: 24333139 [PubMed – indexed for MEDLINE]
Similar articles
38. Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.
Calvet X, Panés J, Alfaro N, Hinojosa J, Sicilia B, Gallego M, Pérez I, Lázaro y de Mercado P, Gomollón F; Members of Consensus Group, Aldeguera X, Alós R, Andreu M, Barreiro M, Bermejo F, Casis B, Domenech E, Espín E, Esteve M, García-Sánchez V, López-Sanromán A, Martínez-Montiel P, Luis Mendoza J, Gisbert JP, Vera M, Dosal A, Sánchez E, Marín L, Sanromán L, Pinilla P, Murciano F, Torrejón A, Ramón García J, Ortega M, Roldán J.
J Crohns Colitis. 2014 Mar;8(3):240-51. doi: 10.1016/j.crohns.2013.10.010. Epub 2013 Dec 2.
PMID: 24295646 [PubMed – indexed for MEDLINE] Free Article
Similar articles
39. [Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU].
Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; en representació del Grupo Espa˜nol de Trabajode Enfermedad de Crohn y Colitis Ulcerosa or Spanish Group for Working on Crohn’sDisease and Ulcerative Colitis (GETECCU).
Gastroenterol Hepatol. 2013 Oct;36(8):e1-47. Spanish. No abstract available.
PMID: 24215088 [PubMed – indexed for MEDLINE]
Similar articles
40. Predictors of favourable outcome in inflammatory Crohn’s disease. A retrospective observational study.
Zabana Y, Garcia-Planella E, van Domselaar M, Mañosa M, Gordillo J, López-Sanromán A, Cabré E, Domènech E.
Gastroenterol Hepatol. 2013 Dec;36(10):616-23. doi: 10.1016/j.gastrohep.2013.07.004. Epub 2013 Sep 7.
PMID: 24021748 [PubMed – indexed for MEDLINE]
Similar articles
41. Disease severity in familial cases of IBD.
Andreu M, Márquez L, Domènech E, Gisbert JP, García V, Marín-Jiménez I, Peñalva M, Gomollón F, Calvet X, Merino O, Garcia-Planella E, Vázquez-Romero N, Esteve M, Nos P, Gutiérrez A, Vera I, Cabriada JL, Martín MD, Cañas-Ventura A, Panés J; Spanish GETECCU group (ENEIDA project).
J Crohns Colitis. 2014 Mar;8(3):234-9. doi: 10.1016/j.crohns.2013.08.010. Epub 2013 Sep 7.
PMID: 24016462 [PubMed – indexed for MEDLINE]
Similar articles
42. Smoking does influence disease behaviour and impacts the need for therapy in Crohn’s disease in the biologic era.
Nunes T, Etchevers MJ, Domènech E, García-Sánchez V, Ber Y, Peñalva M, Merino O, Nos P, Garcia-Planella E, Casbas AG, Esteve M, Taxonera Samsó C, Montoro Huguet M, Gisbert JP, Martín Arranz MD, García-Sepulcre MF, Barreiro-de Acosta M, Beltrán B, Alcaide Suárez N, Saro Gismera C, Cabriada JL, Cañas-Ventura A, Gomollón F, Panés J; Tobacco-Eneida Study Group of GETECCU.
Aliment Pharmacol Ther. 2013 Oct;38(7):752-60. doi: 10.1111/apt.12440. Epub 2013 Aug 26.
PMID: 23980933 [PubMed – indexed for MEDLINE] Free Article
Similar articles
43. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn’s disease.
Panés J, López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A, Taxonera C, Sans M; AZTEC Study Group.
Gastroenterology. 2013 Oct;145(4):766-74.e1. doi: 10.1053/j.gastro.2013.06.009. Epub 2013 Jun 13.
PMID: 23770132 [PubMed – indexed for MEDLINE]
Similar articles
44. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn’s disease: a randomized, double-blind, placebo-controlled trial.
Mañosa M, Cabré E, Bernal I, Esteve M, Garcia-Planella E, Ricart E, Peñalva M, Cortes X, Boix J, Piñol M, Gassull MA, Domènech E.
Inflamm Bowel Dis. 2013 Aug;19(9):1889-95. doi: 10.1097/MIB.0b013e31828ef13f.
PMID: 23689809 [PubMed – indexed for MEDLINE]
Similar articles
45. Current incidence of active tuberculosis in IBD patients treated with anti-TNF agents: still room for improvement.
Mañosa M, Domènech E, Cabré E.
J Crohns Colitis. 2013 Nov;7(10):e499-500. doi: 10.1016/j.crohns.2013.04.021. Epub 2013 May 18. No abstract available.
PMID: 23689076 [PubMed – indexed for MEDLINE]
Similar articles
46. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients.
Zabala W, Cruz R, Barreiro-de Acosta M, Chaparro M, Panes J, Echarri A, Esteve M, Carpio D, Andreu M, García-Planella E, Domenech E, Carracedo A, Gisbert JP, Barros F; EIGA & ENEIDA investigators.
Pharmacogenomics. 2013 Apr;14(6):631-40. doi: 10.2217/pgs.13.38.
PMID: 23570467 [PubMed – indexed for MEDLINE]
Similar articles
47. A systematic review of SAPHO syndrome and inflammatory bowel disease association.
Naves JE, Cabré E, Mañosa M, Grados D, Olivé A, Domènech E.
Dig Dis Sci. 2013 Aug;58(8):2138-47. doi: 10.1007/s10620-013-2653-6. Epub 2013 Mar 30. Review.
PMID: 23543087 [PubMed – indexed for MEDLINE]
Similar articles
48. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.
Mañosa M, Navarro-Llavat M, Marín L, Zabana Y, Cabré E, Domènech E.
Scand J Gastroenterol. 2013 Apr;48(4):427-32. doi: 10.3109/00365521.2013.772229. Epub 2013 Mar 11.
PMID: 23477328 [PubMed – indexed for MEDLINE]
Similar articles
49. [Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].
Cabriada JL, Vera I, Domènech E, Barreiro-de Acosta M, Esteve M, Gisbert JP, Panés J, Gomollón F; Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).
Gastroenterol Hepatol. 2013 Mar;36(3):127-46. doi: 10.1016/j.gastrohep.2013.01.002. Epub 2013 Feb 20. Spanish. No abstract available.
PMID: 23433780 [PubMed – indexed for MEDLINE]
Similar articles
50. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
Casanova MJ, Chaparro M, Domènech E, Barreiro-de Acosta M, Bermejo F, Iglesias E, Gomollón F, Rodrigo L, Calvet X, Esteve M, García-Planella E, García-López S, Taxonera C, Calvo M, López M, Ginard D, Gómez-García M, Garrido E, Pérez-Calle JL, Beltrán B, Piqueras M, Saro C, Botella B, Dueñas C, Ponferrada A, Mañosa M, García-Sánchez V, Maté J, Gisbert JP.
Am J Gastroenterol. 2013 Mar;108(3):433-40. doi: 10.1038/ajg.2012.430. Epub 2013 Jan 15.
PMID: 23318480 [PubMed – indexed for MEDLINE]
Similar articles
51. Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis?
Domènech E, Gisbert JP.
Aliment Pharmacol Ther. 2013 Jan;37(1):160-1. doi: 10.1111/apt.12095. No abstract available.
PMID: 23205480 [PubMed – indexed for MEDLINE] Free Article
Similar articles
52. Sexual function and patients’ perceptions in inflammatory bowel disease: a case-control survey.
Marín L, Mañosa M, Garcia-Planella E, Gordillo J, Zabana Y, Cabré E, Domènech E.
J Gastroenterol. 2013 Jun;48(6):713-20. doi: 10.1007/s00535-012-0700-2. Epub 2012 Nov 3.
PMID: 23124604 [PubMed – indexed for MEDLINE]
Similar articles
53. Effectiveness of infliximab after adalimumab failure in Crohn’s disease.
Chaparro M, Andreu M, Barreiro-de Acosta M, García-Planella E, Ricart E, Domènech E, Esteve M, Merino O, Nos P, Peñalva M, Gisbert JP.
World J Gastroenterol. 2012 Oct 7;18(37):5219-24. doi: 10.3748/wjg.v18.i37.5219.
PMID: 23066316 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
54. Letter: real-life management of new onset ulcerative colitis and proctitis.
Domènech E, Gisbert JP.
Aliment Pharmacol Ther. 2012 Oct;36(7):685-6; author reply 686. doi: 10.1111/apt.12003. No abstract available.
PMID: 22966799 [PubMed – indexed for MEDLINE] Free Article
Similar articles
55. A genome-wide association study on a southern European population identifies a new Crohn’s disease susceptibility locus at RBX1-EP300.
Julià A, Domènech E, Ricart E, Tortosa R, García-Sánchez V, Gisbert JP, Nos Mateu P, Gutiérrez A, Gomollón F, Mendoza JL, Garcia-Planella E, Barreiro-de Acosta M, Muñoz F, Vera M, Saro C, Esteve M, Andreu M, Alonso A, López-Lasanta M, Codó L, Gelpí JL, García-Montero AC, Bertranpetit J, Absher D, Panés J, Marsal S.
Gut. 2013 Oct;62(10):1440-5. doi: 10.1136/gutjnl-2012-302865. Epub 2012 Aug 30.
PMID: 22936669 [PubMed – indexed for MEDLINE]
Similar articles
56. Impact of environmental and dietary factors on the course of inflammatory bowel disease.
Cabré E, Domènech E.
World J Gastroenterol. 2012 Aug 7;18(29):3814-22. doi: 10.3748/wjg.v18.i29.3814. Review.
PMID: 22876032 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
57. Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn’s disease: are antibiotics enough?
Bermejo F, Garrido E, Chaparro M, Gordillo J, Mañosa M, Algaba A, López-Sanromán A, Gisbert JP, García-Planella E, Guerra I, Domènech E.
Inflamm Bowel Dis. 2012 Aug;18(8):1509-14. doi: 10.1002/ibd.21865. Epub 2011 Aug 29.
PMID: 22674826 [PubMed – indexed for MEDLINE]
Similar articles
58. Local injection of infliximab in symptomatic isolated mucosal lesions: a novel scenario for endoscopic therapy?
Lorenzo-Zúñiga V, Boix J, Mañosa M, Lezcano C, Cabré E, Moreno de Vega V, Domènech E.
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E59-61. doi: 10.1002/ibd.23018. No abstract available.
PMID: 22605623 [PubMed – indexed for MEDLINE]
Similar articles
59. Does active smoking really influence the course of Crohn’s disease? A retrospective observational study.
Zabana Y, Garcia-Planella E, Van Domselaar M, Mañosa M, Gordillo J, López San Román A, Cabré E, Domènech E.
J Crohns Colitis. 2013 May;7(4):280-5. doi: 10.1016/j.crohns.2012.03.020. Epub 2012 Apr 25.
PMID: 22537639 [PubMed – indexed for MEDLINE]
Similar articles
60. [Endoscopic management of luminal stenosis in inflammatory bowel disease].
Lorenzo-Zúñiga V, García-Planella E, Moreno De Vega V, Domènech E, Boix J.
Gastroenterol Hepatol. 2012 Jun-Jul;35(6):404-10. doi: 10.1016/j.gastrohep.2011.12.008. Epub 2012 Feb 16. Review. Spanish.
PMID: 22341673 [PubMed – indexed for MEDLINE]
Similar articles
61. Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice.
Naves JE, Lorenzo-Zúñiga V, Marín L, Mañosa M, Oller B, Moreno V, Zabana Y, Boix J, Cabré E, Domènech E.
J Gastrointestin Liver Dis. 2011 Dec;20(4):355-8.
PMID: 22187699 [PubMed – indexed for MEDLINE] Free Article
Similar articles
62. [Systemic amyloidosis in inflammatory bowel disease].
Naves JE, Domènech E.
Gastroenterol Hepatol. 2012 Apr;35(4):259-65. doi: 10.1016/j.gastrohep.2011.11.001. Epub 2011 Dec 15. Review. Spanish.
PMID: 22177266 [PubMed – indexed for MEDLINE]
Similar articles
63. [Mesalazine old and new].
Mañosa M, Domènech E.
Gastroenterol Hepatol. 2011 Dec;34 Suppl 3:25-9. doi: 10.1016/S0210-5705(11)70095-4. Epub 2014 Oct 30. Review. Spanish.
PMID: 25443223 [PubMed – indexed for MEDLINE]
Similar articles
64. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.
Cabriada JL, Domènech E, Ibargoyen N, Hernández V, Clofent J, Ginard D, Gutiérrez-Ibarluzea I, Hinojosa J.
J Gastroenterol. 2012 Apr;47(4):359-65. doi: 10.1007/s00535-011-0499-2. Epub 2011 Nov 23.
PMID: 22105230 [PubMed – indexed for MEDLINE]
Similar articles
65. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
Garcia-Planella E, Mañosa M, Van Domselaar M, Gordillo J, Zabana Y, Cabré E, López San Román A, Domènech E.
Dig Liver Dis. 2012 Mar;44(3):206-10. doi: 10.1016/j.dld.2011.10.004. Epub 2011 Nov 11.
PMID: 22079262 [PubMed – indexed for MEDLINE]
Similar articles
66. Management of Crohn’s disease in smokers: is an alternative approach necessary?
Nos P, Domènech E.
World J Gastroenterol. 2011 Aug 21;17(31):3567-74. doi: 10.3748/wjg.v17.i31.3567. Review.
PMID: 21987601 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
67. Should we monitor Crohn’s disease patients for postoperative recurrence after permanent ileostomy?
Leal-Valdivieso C, Marín I, Mañosa M, Naves JE, Zabana Y, Piñol M, Cabré E, Domènech E.
Inflamm Bowel Dis. 2012 Jan;18(1):E196. doi: 10.1002/ibd.21730. Epub 2011 Oct 10. No abstract available.
PMID: 21987356 [PubMed – indexed for MEDLINE]
Similar articles
68. Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease.
Cariñanos I, Acosta MB, Domènech E.
Inflamm Bowel Dis. 2011 Dec;17(12):E153-4. doi: 10.1002/ibd.21723. Epub 2011 Sep 26. No abstract available.
PMID: 21953808 [PubMed – indexed for MEDLINE]
Similar articles
69. Therapeutic effect of antisecretory factor-rich egg yolk on the late phases of 2,4,6-trinitrobenzenesulphonic acid colitis in mice.
Mañé J, Lorén V, Pedrosa E, Ojanguren I, Domènech E, Gassull MA, Cabré E.
Br J Nutr. 2011 Nov;106(10):1522-8. doi: 10.1017/S0007114511002042. Epub 2011 Jul 1.
PMID: 21733301 [PubMed – indexed for MEDLINE]
Similar articles
70. Perianal disease in patients with ulcerative colitis: A case-control study.
Zabana Y, Van Domselaar M, Garcia-Planella E, Mañosa M, San Román AL, Gordillo J, Cabré E, Domènech E.
J Crohns Colitis. 2011 Aug;5(4):338-41. doi: 10.1016/j.crohns.2011.02.011. Epub 2011 Mar 10.
PMID: 21683304 [PubMed – indexed for MEDLINE]
Similar articles
71. Long-term durability of response to adalimumab in Crohn’s disease.
Chaparro M, Panés J, García V, Merino O, Nos P, Domènech E, Peñalva M, García-Planella E, Esteve M, Hinojosa J, Andreu M, Muñoz F, Gutiérrez A, Mendoza JL, Barrio J, Barreiro-de M, Vera I, Vilar P, Cabriada JL, Montoro MA, Aldeguer X, Saro C, Gisbert JP.
Inflamm Bowel Dis. 2012 Apr;18(4):685-90. doi: 10.1002/ibd.21758. Epub 2011 May 25.
PMID: 21618353 [PubMed – indexed for MEDLINE]
Similar articles
72. Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids.
Mañosa M, Cabré E, Garcia-Planella E, Bernal I, Gordillo J, Esteve M, Zabana Y, Gassull MA, Domènech E.
Inflamm Bowel Dis. 2011 Dec;17(12):2497-502. doi: 10.1002/ibd.21634. Epub 2011 Apr 6.
PMID: 21472824 [PubMed – indexed for MEDLINE]
Similar articles
73. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome.
Serra I, Oller B, Mañosa M, Naves JE, Zabana Y, Cabré E, Domènech E.
J Crohns Colitis. 2010 Sep;4(3):269-74. doi: 10.1016/j.crohns.2009.11.009.
PMID: 21122515 [PubMed – indexed for MEDLINE]
Similar articles
74. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease.
Domènech E, Carrión S, Garcia-Planella E, Mañosa M, Gordillo J, Concepción M, Guarner C, Cabré E.
Inflamm Bowel Dis. 2011 Apr;17(4):971-5. doi: 10.1002/ibd.21456. Epub 2010 Sep 7.
PMID: 20824819 [PubMed – indexed for MEDLINE]
Similar articles
75. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
Loras C, Gisbert JP, Mínguez M, Merino O, Bujanda L, Saro C, Domenech E, Barrio J, Andreu M, Ordás I, Vida L, Bastida G, González-Huix F, Piqueras M, Ginard D, Calvet X, Gutiérrez A, Abad A, Torres M, Panés J, Chaparro M, Pascual I, Rodriguez-Carballeira M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study; GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group.
Gut. 2010 Oct;59(10):1340-6. doi: 10.1136/gut.2010.208413. Epub 2010 Jun 24.
PMID: 20577000 [PubMed – indexed for MEDLINE]
Similar articles
76. [How long should combined therapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?].
Domènech E, López San Román A, Garcia-Planella E.
Gastroenterol Hepatol. 2010 Jun-Jul;33(6):471-2; author reply 472-3. doi: 10.1016/j.gastrohep.2010.02.008. Epub 2010 Jun 24. Spanish. No abstract available.
PMID: 20435379 [PubMed – indexed for MEDLINE]
Similar articles
77. [Portal hypertension in patients with inflammatory bowel disease].
Leal-Valdivieso C, Naves JE, Mañosa M, Zabana Y, Cabré E, Domènech E.
Gastroenterol Hepatol. 2010 Apr;33(4):297-302. doi: 10.1016/j.gastrohep.2009.12.003. Epub 2010 Mar 4. Spanish.
PMID: 20206413 [PubMed – indexed for MEDLINE]
Similar articles
78. Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice.
Zabana Y, Domènech E, Mañosa M, Garcia-Planella E, Bernal I, Cabré E, Gassull MA.
Aliment Pharmacol Ther. 2010 Mar;31(5):553-60. doi: 10.1111/j.1365-2036.2009.04206.x. Epub 2009 Nov 30.
PMID: 20002026 [PubMed – indexed for MEDLINE] Free Article
Similar articles
79. Clinical outcome of newly diagnosed Crohn’s disease: a comparative, retrospective study before and after infliximab availability.
Domènech E, Zabana Y, Garcia-Planella E, López San Román A, Nos P, Ginard D, Gordillo J, Martínez-Silva F, Beltrán B, Mañosa M, Cabré E, Gassull MA.
Aliment Pharmacol Ther. 2010 Jan 15;31(2):233-9. doi: 10.1111/j.1365-2036.2009.04170.x. Epub 2009 Oct 13.
PMID: 19832727 [PubMed – indexed for MEDLINE] Free Article
Similar articles
80. Top-down therapy: is the evidence strong enough?
Domènech E, Mañosa M, Cabré E.
Dig Dis. 2009;27(3):306-11. doi: 10.1159/000228565. Epub 2009 Sep 24. Review.
PMID: 19786756 [PubMed – indexed for MEDLINE]
Similar articles
81. Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab.
Carrión S, Domènech E, Romeu J.
J Crohns Colitis. 2009 Sep;3(3):220-1. doi: 10.1016/j.crohns.2009.04.004. Epub 2009 Jun 10. No abstract available.
PMID: 21172278 [PubMed]
Similar articles
82. [Apheresis in inflammatory bowel disease].
Nos P, Domènech E.
Gastroenterol Hepatol. 2009 Aug-Sep;32(7):509-18. doi: 10.1016/j.gastrohep.2009.01.183. Epub 2009 Jul 15. Review. Spanish.
PMID: 19608298 [PubMed – indexed for MEDLINE]
Similar articles
83. Does methotrexate induce mucosal healing in Crohn’s disease?
Mañosa M, Naves JE, Leal C, Cabré E, Moreno V, Lorenzo-Zuñiga V, Boix J, Domènech E.
Inflamm Bowel Dis. 2010 Mar;16(3):377-8. doi: 10.1002/ibd.21015. No abstract available.
PMID: 19575354 [PubMed – indexed for MEDLINE]
Similar articles
84. [Psoas abscess as a complication of Crohn’s disease: report of three cases and literature review].
Marín I, Serra I, Mañosa M, Cabré E, Domènech E.
Gastroenterol Hepatol. 2009 Oct;32(8):557-61. doi: 10.1016/j.gastrohep.2009.03.004. Epub 2009 Jun 17. Review. Spanish.
PMID: 19539402 [PubMed – indexed for MEDLINE]
Similar articles
85. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D’Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF; European Crohn’s and Colitis Organisation (ECCO).
J Crohns Colitis. 2009 Jun;3(2):47-91. doi: 10.1016/j.crohns.2009.02.010. Epub 2009 Apr 26. No abstract available.
PMID: 21172250 [PubMed] Free Article
Similar articles
86. Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.
Mañosa M, López San Román A, Garcia-Planella E, Bastida G, Hinojosa J, Gonzalez-Lama Y, Masnou H, Domènech E.
Digestion. 2009;80(1):30-5. doi: 10.1159/000212075. Epub 2009 May 14.
PMID: 19439969 [PubMed – indexed for MEDLINE]
Similar articles
87. Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients.
Navarro-Llavat M, Domènech E, Bernal I, Sánchez-Delgado J, Manterola JM, Garcia-Planella E, Mañosa M, Cabré E, Gassull MA.
Digestion. 2009;80(1):25-9. doi: 10.1159/000212076. Epub 2009 May 14.
PMID: 19439968 [PubMed – indexed for MEDLINE]
Similar articles
88. Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients with inflammatory bowel disease initially treated with a three-infusion induction regimen.
Domènech E, Zabana Y, Mañosa M, Garcia-Planella E, Cabré E, Gassull MA.
J Clin Gastroenterol. 2010 Jan;44(1):34-7. doi: 10.1097/MCG.0b013e3181962dfa.
PMID: 19417683 [PubMed – indexed for MEDLINE]
Similar articles
89. Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice.
Mañé J, Lorén V, Pedrosa E, Ojanguren I, Xaus J, Cabré E, Domènech E, Gassull MA.
Inflamm Bowel Dis. 2009 Aug;15(8):1155-63. doi: 10.1002/ibd.20908.
PMID: 19266568 [PubMed – indexed for MEDLINE]
Similar articles
90. Impact of capsule endoscopy findings in the management of Crohn’s Disease.
Lorenzo-Zúñiga V, de Vega VM, Domènech E, Cabré E, Mañosa M, Boix J.
Dig Dis Sci. 2010 Feb;55(2):411-4. doi: 10.1007/s10620-009-0758-8. Epub 2009 Mar 3.
PMID: 19255845 [PubMed – indexed for MEDLINE]
Similar articles
91. Cervical dysplasia in immunosuppressed IBD women.
Zabana Y, Barreiro M, Mañosa M, Lorenzo A, Cabré E, Domènech E.
Inflamm Bowel Dis. 2009 Dec;15(12):1774. doi: 10.1002/ibd.20878. Epub 2009 Jan 14. No abstract available.
PMID: 19145640 [PubMed – indexed for MEDLINE]
Similar articles
92. Postoperative Crohn’s disease recurrence: a practical approach.
Nos P, Domenech E.
World J Gastroenterol. 2008 Sep 28;14(36):5540-8. Review.
PMID: 18810773 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles
93. Infliximab use in a patient with ulcerative colitis and alcoholic cirrhosis with portal hypertension.
Carrión S, Marín I, Domènech E.
J Crohns Colitis. 2008 Sep;2(3):271-2. doi: 10.1016/j.crohns.2008.05.008. Epub 2008 Jul 3. No abstract available.
PMID: 21172224 [PubMed]
Similar articles
94. Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy.
Zabana Y, Domènech E, San Román AL, Beltrán B, Cabriada JL, Saro C, Araméndiz R, Ginard D, Hinojosa J, Gisbert JP, Mañosa M, Cabré E, Gassull MA.
Inflamm Bowel Dis. 2008 Oct;14(10):1387-91. doi: 10.1002/ibd.20496.
PMID: 18452206 [PubMed – indexed for MEDLINE]
Similar articles
95. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy.
Domènech E, Vega R, Ojanguren I, Hernández A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E, Gassull MA.
Inflamm Bowel Dis. 2008 Oct;14(10):1373-9. doi: 10.1002/ibd.20498.
PMID: 18452205 [PubMed – indexed for MEDLINE]
Similar articles
96. [Infectious mononucleosis in patients with inflammatory bowel disease under treatment with azathioprine].
Bargalló A, Carrión S, Domènech E, Arévalo JA, Mañosa M, Cabré E, Cabriada JL, Gassull MA.
Gastroenterol Hepatol. 2008 May;31(5):289-92. Review. Spanish.
PMID: 18448058 [PubMed – indexed for MEDLINE]
Similar articles
97. Adalimumab-induced lupus erythematosus in Crohn’s disease patients previously treated with infliximab.
Mañosa M, Domènech E, Marín L, Olivé A, Zabana Y, Cabré E, Gassull MA.
Gut. 2008 Apr;57(4):559; author reply 559-60. No abstract available.
PMID: 18334664 [PubMed – indexed for MEDLINE]
Similar articles
98. Long-term methotrexate for Crohn’s disease: safety and efficacy in clinical practice.
Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.
J Clin Gastroenterol. 2008 Apr;42(4):395-9. doi: 10.1097/MCG.0b013e31802e6875.
PMID: 18277899 [PubMed – indexed for MEDLINE]
Similar articles
99. Impact of azathioprine on the prevention of postoperative Crohn’s disease recurrence: results of a prospective, observational, long-term follow-up study.
Domènech E, Mañosa M, Bernal I, Garcia-Planella E, Cabré E, Piñol M, Lorenzo-Zúñiga V, Boix J, Gassull MA.
Inflamm Bowel Dis. 2008 Apr;14(4):508-13. doi: 10.1002/ibd.20359. Erratum in: Inflamm Bowel Dis. 2008 Dec;14(12):1761.
PMID: 18183602 [PubMed – indexed for MEDLINE]
Similar articles
100. Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort.
Aceituno M, García-Planella E, Heredia C, Zabana Y, Feu F, Domènech E, Gassull MA, Panés J.
Inflamm Bowel Dis. 2008 Mar;14(3):347-52.
PMID: 18050296 [PubMed – indexed for MEDLINE]
Similar articles
101. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?
Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E, Badia X.
Dig Liver Dis. 2007 Jul;39(7):617-25. Epub 2007 May 24.
PMID: 17531555 [PubMed – indexed for MEDLINE]
Similar articles
102. [Acute appendicitis in inactive extensive ulcerative colitis].
Zabana Y, Domènech E, Latorre N, Ojanguren I, Mañosa M, Gassull MA.
Gastroenterol Hepatol. 2007 Feb;30(2):69-73. Spanish.
PMID: 17335713 [PubMed – indexed for MEDLINE]
Similar articles
103. Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis.
Lorén V, Manyé J, Fuentes MC, Cabré E, Ojanguren I, Espadaler J.
Probiotics Antimicrob Proteins. 2017 Mar;9(1):71-80. doi: 10.1007/s12602-016-9239-5.
PMID: 27832441 [PubMed – in process]
Similar articles
104. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
Chaparro M, Ordás I, Cabré E, Garcia-Sanchez V, Bastida G, Peñalva M, Gomollón F, García-Planella E, Merino O, Gutiérrez A, Esteve M, Márquez L, Garcia-Sepulcre M, Hinojosa J, Vera I, Muñoz F, Mendoza JL, Cabriada JL, Montoro MA, Barreiro-de Acosta M, Ceña G, Saro C, Aldeguer X, Barrio J, Maté J, Gisbert JP.
Inflamm Bowel Dis. 2013 Jun;19(7):1404-10. doi: 10.1097/MIB.0b013e318281f28f.
PMID: 23665964 [PubMed – indexed for MEDLINE]
Similar articles
105. Omega-3 fatty acids and inflammatory bowel diseases – a systematic review.
Cabré E, Mañosa M, Gassull MA.
Br J Nutr. 2012 Jun;107 Suppl 2:S240-52. doi: 10.1017/S0007114512001626. Review.
PMID: 22591898 [PubMed – indexed for MEDLINE]
Similar articles
106. Multidisciplinary consensus on the approach to hospital malnutrition in Spain.
García de Lorenzo A, Álvarez Hernández J, Planas M, Burgos R, Araujo K; multidisciplinary consensus work-team on the approach to hospital malnutrition in Spain.
Nutr Hosp. 2011 Jul-Aug;26(4):701-10. doi: 10.1590/S0212-16112011000400006. Review.
PMID: 22470013 [PubMed – indexed for MEDLINE] Free Article
Similar articles
107. Bacteria and spontaneous experimental colitis: immunological changes.
Pedrosa E, Lorén V, Cabré E, Doménech E, Ojanguren I, Gassull MA, Mañé J.
Eur J Clin Invest. 2011 Oct;41(10):1047-53. doi: 10.1111/j.1365-2362.2011.02499.x. Epub 2011 Mar 9.
PMID: 21902690 [PubMed – indexed for MEDLINE]
Similar articles
108. A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial.
Mañé J, Pedrosa E, Lorén V, Gassull MA, Espadaler J, Cuñé J, Audivert S, Bonachera MA, Cabré E.
Nutr Hosp. 2011 Jan-Feb;26(1):228-35.
PMID: 21519752 [PubMed – indexed for MEDLINE] Free Article
Similar articles
109. On the second ECCO Consensus on Crohn’s disease.
Travis S, Van Assche G, Dignass A, Cabré E, Gassull MA.
J Crohns Colitis. 2010 Feb;4(1):1-6. doi: 10.1016/j.crohns.2010.01.002. No abstract available.
PMID: 21122487 [PubMed – indexed for MEDLINE] Free Article
Similar articles
110. ESPEN Guidelines on Parenteral Nutrition: gastroenterology.
Van Gossum A, Cabre E, Hébuterne X, Jeppesen P, Krznaric Z, Messing B, Powell-Tuck J, Staun M, Nightingale J; ESPEN.
Clin Nutr. 2009 Aug;28(4):415-27. doi: 10.1016/j.clnu.2009.04.022. Epub 2009 Jun 9.
PMID: 19515465 [PubMed – indexed for MEDLINE]
Similar articles
111. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice.
Mañé J, Pedrosa E, Lorén V, Ojanguren I, Fluvià L, Cabré E, Rogler G, Gassull MA.
J Nutr. 2009 Mar;139(3):603-10. doi: 10.3945/jn.108.101170. Epub 2009 Jan 6.
PMID: 19126671 [PubMed – indexed for MEDLINE] Free Article
Similar articles
112. Probiotics for preventing relapse or recurrence in Crohn’s disease involving the ileum: Are there reasons for failure?
Cabré E, A Gassull M.
J Crohns Colitis. 2007 Sep;1(1):47-52. doi: 10.1016/j.crohns.2007.06.003.
PMID: 21172184 [PubMed]
Similar articles
113. Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Guerra I, Pérez-Jeldres T, Iborra M, Algaba A, Monfort D, Calvet X, Chaparro M, Mañosa M, Hinojosa E, Minguez M, Ortiz de Zarate J, Márquez L, Prieto V, García-Sánchez V, Guardiola J, Rodriguez GE, Martín-Arranz MD, García-Tercero I, Sicilia B, Masedo Á, Lorente R, Rivero M, Fernández-Salazar L, Gutiérrez A, Van Domselaar M, López-SanRomán A, Ber Y, García-Sepulcre M, Ramos L, Bermejo F, Gisbert JP; Spanish GETECCU group (ENEIDA project).
Inflamm Bowel Dis. 2016 Apr;22(4):894-901. doi: 10.1097/MIB.0000000000000757.
PMID: 26933750 [PubMed – indexed for MEDLINE]
Similar articles
114. Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.
Carpio D, Jauregui-Amezaga A, de Francisco R, de Castro L, Barreiro-de Acosta M, Mendoza JL, Mañosa M, Ollero V, Castro B, González-Conde B, Hervías D, Sierra Ausin M, Sancho Del Val L, Botella-Mateu B, Martínez-Cadilla J, Calvo M, Chaparro M, Ginard D, Guerra I, Maroto N, Calvet X, Fernández-Salgado E, Gordillo J, Rojas Feria M; GETECCU.
J Crohns Colitis. 2016 Oct;10(10):1186-93. doi: 10.1093/ecco-jcc/jjw022. Epub 2016 Jan 22.
PMID: 26802085 [PubMed – indexed for MEDLINE]
Similar articles
115. Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.
Barreiro-de Acosta M, García-Bosch O, Gordillo J, Mañosa M, Menchén L, Souto R, Marin-Jimenez I; Grupo Joven GETECCU.
Eur J Gastroenterol Hepatol. 2012 Jul;24(7):756-8. doi: 10.1097/MEG.0b013e3283525a7b.
PMID: 22395225 [PubMed – indexed for MEDLINE]
Similar articles
116. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M, Burgueño P, Iglesias E, Panés J, Muñoz F, Bastida G, Castro L, Jiménez C, Mendoza JL, Barreiro-de Acosta M, Senent SG, Gomollón F, Calvet X, García-Planella E, Gómez M, Hernández V, Hinojosa J, Mañosa M, Nyssen OP, Gisbert JP.
Aliment Pharmacol Ther. 2012 Jan;35(2):275-83. doi: 10.1111/j.1365-2036.2011.04934.x. Epub 2011 Dec 5.
PMID: 22142227 [PubMed – indexed for MEDLINE] Free Article
Similar articles
117. Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy.
Mañosa M, García V, Castro L, García-Bosch O, Chaparro M, Barreiro-de Acosta M, Carpio D, Aguas M.
J Crohns Colitis. 2011 Oct;5(5):397-401. doi: 10.1016/j.crohns.2011.03.012. Epub 2011 Apr 22.
PMID: 21939912 [PubMed – indexed for MEDLINE]
Similar articles
118. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.
Barreiro-de Acosta M, García-Bosch O, Souto R, Mañosa M, Miranda J, García-Sanchez V, Gordillo J, Chacon S, Loras C, Carpio D, Maroto N, Menchén L, Rojas-Feria M, Sierra M, Villoria A, Marin-Jimenez I; Grupo joven GETECCU.
Inflamm Bowel Dis. 2012 May;18(5):812-7. doi: 10.1002/ibd.21821. Epub 2011 Aug 8.
PMID: 21826765 [PubMed – indexed for MEDLINE]
Similar articles
119. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn’s disease.
Santaolalla R, Mañé J, Pedrosa E, Lorén V, Fernández-Bañares F, Mallolas J, Carrasco A, Salas A, Rosinach M, Forné M, Espinós JC, Loras C, Donovan M, Puig P, Mañosa M, Gassull MA, Viver JM, Esteve M.
Inflamm Bowel Dis. 2011 Jul;17(7):1490-500. doi: 10.1002/ibd.21507. Epub 2010 Nov 8.
PMID: 21674705 [PubMed – indexed for MEDLINE]
Similar articles
120. Long-term durability of infliximab treatment in Crohn’s disease and efficacy of dose “escalation” in patients losing response.
Chaparro M, Panes J, García V, Mañosa M, Esteve M, Merino O, Andreu M, Gutierrez A, Gomollón F, Cabriada JL, Montoro MA, Mendoza JL, Nos P, Gisbert JP.
J Clin Gastroenterol. 2011 Feb;45(2):113-8. doi: 10.1097/MCG.0b013e3181ebaef9.
PMID: 21242747 [PubMed – indexed for MEDLINE]
Similar articles
121. [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].
García-Planella E, Marín L, Domènech E, Bernal I, Mañosa M, Zabana Y, Gassull MA.
Med Clin (Barc). 2007 Jan 20;128(2):45-8. Spanish.
PMID: 17266900 [PubMed – indexed for MEDLINE]
Similar articles
122. Comparison of lymphocyte isolation methods for endoscopic biopsy specimens from the colonic mucosa.
Carrasco A, Mañe J, Santaolalla R, Pedrosa E, Mallolas J, Lorén V, Fernández M, Fernández-Bañares F, Rosinach M, Loras C, Forné M, Andújar X, Vidal J, Viver JM, Esteve M.
J Immunol Methods. 2013 Mar 29;389(1-2):29-37. doi: 10.1016/j.jim.2012.12.006. Epub 2012 Dec 30.
PMID: 23279944 [PubMed – indexed for MEDLINE]
Similar articles

 

 

Anuncis